Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410824 · ClinicalTrials.gov registry record · NA
Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02410824 is a NA study that has completed, run by CooperVision. The registered enrollment target is 52 participants.
The verdict
NCT02410824, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Bilateral dispensing clinical trial of stenfilcon A against etafilcon A for astigmatism.
Interventions
- DEVICE stenfilcon A toric lens
- DEVICE etafilcon A toric lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410824
The ClinicalTrials.gov registry entry for NCT02410824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which stenfilcon A toric lens is the first listed.
NCT02410824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410824 about?
NCT02410824 is a clinical study titled "Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism". Bilateral dispensing clinical trial of stenfilcon A against etafilcon A for astigmatism.
What is the current status of trial NCT02410824?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2015-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02410824?
The interventions under investigation include: stenfilcon A toric lens (DEVICE), etafilcon A toric lens (DEVICE).
Who is sponsoring clinical trial NCT02410824?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.